Microdosing Tirzepatide Chart: Dose Guide

The single most important fact about reading any tirzepatide chart: units are meaningless without the reconstitution ratio. The same 1 mg dose can be 5 units or 20 units depending on how much bacteriostatic water you added. Always match your chart to your mixing ratio.

At 10 mg/mL (common: 10 mg vial + 1 mL bac water):

At 5 mg/mL (10 mg vial + 2 mL bac water):

Lower concentration means more units per dose, which makes small microdoses easier to measure accurately on a U-100 syringe. Use the peptide unit converter to check any ratio not listed here.

Microdosing borrows a term from other fields, but here it has a specific meaning: dosing below the lowest labeled clinical dose. Tirzepatide's approved schedule begins at 2.5 mg weekly and titrates up to as high as 15 mg (Jastreboff et al., N Engl J Med, 2022). Anything under 2.5 mg is a microdose.

Think of it like seasoning food. The recipe calls for a full teaspoon, but some people are sensitive and prefer a pinch that still flavors the dish without overwhelming it. Microdosing tirzepatide aims for enough GLP-1 and GIP receptor activation to blunt appetite while staying under the threshold that triggers harsh nausea.

The trade-off is predictable. Lower doses mean fewer and milder side effects but slower or smaller weight loss. For some users, especially those maintaining a goal weight or extremely sensitive to GI effects, that trade is exactly what they want. For aggressive fat loss, microdosing underperforms standard titration.

Microdosing is an off-label practice. No clinical trial validated sub-2.5 mg dosing for efficacy. See what is microdosing tirzepatide for the full background.

Four motivations drive almost every microdosing decision. Knowing which one applies to you shapes the right chart row to target.

Side-effect control. Nausea, constipation, and fatigue scale with dose. Users who cannot tolerate 2.5 mg sometimes start at 1 mg and climb slowly. See does tirzepatide cause constipation and does tirzepatide make you tired.

Maintenance after weight loss. After reaching a goal, many people drop to the smallest dose that prevents regain rather than stopping entirely. Our tirzepatide maintenance dose after weight loss guide covers this in depth.

Budget and vial stretching. A 10 mg vial used at 1 mg weekly lasts ten weeks instead of four. Microdosing cuts monthly cost substantially.

Sensitivity and small frames. Smaller or older users sometimes find standard doses too strong and prefer a gentler entry.

Each goal points to a different part of the chart. A maintenance user might sit at 1.5-2 mg, while someone purely controlling side effects on the way up might pause at 1 mg before escalating.

If you microdose as a gentle on-ramp rather than a permanent protocol, a slow climb gives your gut time to adapt. This sample schedule is conservative and assumes a 10 mg/mL mix.

Hold at any step longer if side effects appear. There is no prize for rushing. The point of microdosing is comfort, and escalating before your gut adapts defeats the purpose.

Maintenance users run this in reverse, settling at the lowest dose that holds their weight. For the standard above-microdose schedule, see our tirzepatide dosage chart in units and the tirzepatide dosage calculator.

The hardest part of microdosing is precision. A 5-unit dose leaves almost no margin for error on a standard syringe, and a small slip is a large percentage of the dose.

Use the right syringe. A U-100 insulin syringe with half-unit or single-unit markings is essential. The smaller the barrel (0.3 mL), the easier small doses are to read.

Dilute for easier measurement. Reconstituting at a lower concentration (5 mg/mL instead of 10 mg/mL) doubles the units per dose, spreading a tiny dose across more visible markings. A 0.5 mg dose at 5 mg/mL is 10 units instead of 5, which is far easier to draw accurately.

Draw at eye level. Hold the syringe vertically, tap out air bubbles, and read the plunger line straight on to avoid parallax error.

Reconstitute consistently. Use the same bac water volume every time so your chart stays valid. Changing the ratio mid-vial invalidates every unit conversion. See how to reconstitute tirzepatide and how much bacteriostatic water for semaglutide for the same mixing principles.

Accuracy matters more at microdoses than at standard doses, because the error is proportionally larger.

Microdosing is not a free lunch. It buys tolerability at the cost of speed and, sometimes, total results.

The clinical weight-loss results everyone cites came from standard titration up to 10-15 mg, not microdoses (Jastreboff et al., N Engl J Med, 2022). If your goal is the dramatic loss seen in trials, microdosing will likely disappoint. If your goal is comfortable maintenance or a gentle start, it fits well.

Be honest about which camp you are in. Many people microdose hoping for full results with no side effects, then feel the protocol failed when it was never designed for that. See why am I not losing weight on tirzepatide if results stall.

Mistake 1: Reading a units chart without checking the ratio. A chart built for 10 mg/mL is wrong if you mixed at 5 mg/mL. The fix: always match the chart to your exact reconstitution.

Mistake 2: Using a 1 mL syringe for tiny doses. Large-barrel syringes make 5-unit doses nearly impossible to read. The fix: use a 0.3 mL U-100 syringe.

Mistake 3: Expecting trial-level weight loss. Microdoses were never tested for the dramatic results seen at 10-15 mg. The fix: set realistic expectations or escalate to standard dosing.

Mistake 4: Changing the mixing ratio mid-vial. This silently invalidates every unit conversion you have memorized. The fix: reconstitute the same way every time.

Mistake 5: Microdosing to mask a quality problem. If a vial seems weak, microdosing will not fix underdosed or degraded product. The fix: verify your source and storage. See does tirzepatide expire and how long does tirzepatide last in the fridge.